Find your next paid study

Novartis PharmaceuticalsNCT06597006

~$50 – $2,100

Actual pay is set by the research site.

Blood CancerLymphomaLeukemia+1 more

Pilot Trial of Telehealth Music Therapy for Cognitive Dysfunction in Hematologic Cancer Survivors (PRELUDE)

Research has shown that music-based activities may help improve brain functions, such as attention, memory, and executive function. Because of this past resear…

Memorial Sloan Kettering Cancer CenterNCT07052916

~$10 – $750

Actual pay is set by the research site.

Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation

Prospective cohort study evaluating the electrophysiologic and biochemical effects of stellate ganglion block in patients with ventricular tachycardia.

Ventricular Tachycardia

University of PennsylvaniaNCT05377216

~$150 – $3,000

Actual pay is set by the research site.

Clear Cell Renal Cell Carcinoma

A Phase 1 Study Of LNK001 (Dual ENPP3/CAIX AND-gate CAR T Cell Therapy) In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

There are 2 parts to this clinical research study: Part 1 (Dose Escalation) and Part 2 (Dose Expansion). The goal of Part 1 is to find the recommended dose of…

M.D. Anderson Cancer CenterNCT07564232

~$150 – $3,000

Actual pay is set by the research site.

Degenerative Disc DiseaseSpine FusionBack Pain

A Prospective, Randomized, Multi-Center Study to Assess the Safety and Performance of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers (DBX or Grafton) Mixed With Local Autograft in Patients Undergoing One to Two-Level Instrumented Posterolateral Lumbar/Thoracolumbar Fusion (PLF)

This is a phase IV post-marketing study for MagnetOs Easypack Putty. MagnetOs Easypack Putty is a synthetic bone graft extender product that is routinely used …

Kuros Biosurgery AGNCT04679844

~$10 – $1,050

Actual pay is set by the research site.

Phase 2

TAGGED: A Phase 2 Study Using Low Dose/Metronomic Trabectedin, Gemcitabine, and Dacarbazine as 2nd/3rd/4th Line Therapy for Advanced Soft Tissue Sarcoma

This is an open label phase 2 study using metronomic doses of trabectedin, gemcitabine and dacarbazine given intravenously.

Leiomyosarcoma

Sarcoma Oncology Research Center, LLCNCT04535271

~$75 – $2,000

Actual pay is set by the research site.

Phase 2

A Phase 2, Open-label, Multicenter, Single-arm Trial of JNJ-101556143, an Androgen Receptor-targeted Regulated Induced Proximity Targeting Chimera (RIPTAC™) Therapeutic in Participants With Metastatic Androgen Pathway Modulation-Resistant Prostate Cancer

The purpose of this study is to evaluate how well JNJ-101556143 works in participants with metastatic androgen pathway modulation-resistant prostate cancer (mA…

Prostatic Neoplasms

Janssen Research & Development, LLCNCT07832292

~$75 – $2,800

Actual pay is set by the research site.

Substance Use Disorder (SUD)

Hybrid Type I Trial of a Peer-Led Court Navigation Program to Improve Substance Use Disorder Treatment Receipt and Reduce Overdose and Incarceration Among People Passing Through Courthouses

This project is a hybrid type I clinical trial to assess the effectiveness and implementation determinants of a peer-led court navigation program for people wh…

RTI InternationalNCT07700407

~$10 – $1,125

Actual pay is set by the research site.

Phase 4

Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and t…

Multiple Myeloma

Janssen Research & Development, LLCNCT05201781

~$25 – $1,400

Actual pay is set by the research site.

Severe Hepatic ImpairmentNormal Hepatic Function

A Phase 1, Open-Label, Non-randomized, Single Dose, Safety, Tolerability, and Pharmacokinetic Study of Vorasidenib Administered to Participants With Severe Hepatic Impairment and Matched-Participants With Normal Hepatic Function

The objective of this study is to evaluate the pharmacokinetics, safety, and tolerability of one dose of vorasidenib in participants with severe impaired hepat…

Institut de Recherches Internationales Servier (I.R.I.S.)NCT07250633

~$500 – $11,250

Actual pay is set by the research site.

Recurrent Glioblastoma, IDH-WildtypeRecurrent MGMT-Methylated Glioblastoma

A Phase 1 and Randomized Phase 2 Trial of Selinexor and Temozolomide in Recurrent Glioblastoma

This phase I/II trial tests the safety, side effects and best dose of selinexor given in combination with the usual chemotherapy (temozolomide) and compares th…

National Cancer Institute (NCI)NCT05432804

~$150 – $2,700

Actual pay is set by the research site.

Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department

The purpose of this study is to offer routine lab-based and rapid point of care (POC) syphilis diagnostic testing in the emergency department (ED) and obstetri…

Syphilis